Watch the full episode on YouTube to hear Prof. Francesco Giorgino (EASD President) and Prof. Leszek Czupryniak (EASD Global Council Advisor) introduce EASD's newest initiative: the Global Council, launched in Madrid in 2023. This 13-member council brings together diabetes experts from Asia, North and South America, Africa, the Middle East, Australia, and underrepresented regions of Europe to provide direct, active contributions to EASD activities and address global challenges in diabetes research and care. The council's first major achievement is a comprehensive paper published in Diabetologia that identifies global challenges for diabetes research, care, and organizations from a unique perspective - starting from research but extending into practical care delivery. Learn how experts from every continent are working together to address global challenges, promote equity, and celebrate excellence in diabetes research.

The episode also announces a historic milestone: EASD's first new prize in nearly 60 years - the inaugural Global Impact Prize for Diabetes awarded to Dr. Viswanathan Mohan from India for pioneering work in diabetes epidemiology and subtypes in Asia in 2025 - a testament to the importance of global perspectives in diabetes research.

Looking forward, the council is developing global structures for registries, supporting research development in underserved regions, and moving from hopes to concrete solutions

Explore the EASD 2025 Global Impact Prize Lecture in Vienna and view our speakers’ profiles:

For more content from our previous episodes, visit our podcast archive.

In this episode, a cardiologist (Dr. Kieran Docherty), an epidemiologist (Dr. Paul Welsh) and a diabetologist (Dr. Hertzel C. Gerstein) discuss the growing overlap between diabetes and cardiovascular disease and why collaboration across specialties is essential for patient care. Watch the full episode on YouTube to learn more about how collaboration across disciplines is shaping the future of diabetes and cardiovascular medicine.

Topics discussed include:

🎥 Explore the related full EASD-ESC Joint Symposium session and learn more about our expert speakers via the EASD Media Centre:

🎧 Discover previous episodes of Diabetes Insights in our podcast archive.

Watch the full episode on YouTube to explore how circadian rhythms, meal timing, and exercise interact with metabolism and diabetes risk. Prof. Frédéric Gachon and Prof. Olga Pivovarova-Ramich discuss why _when _we eat matters, how chronotype influences insulin sensitivity and body weight, and what current evidence tells us about intermittent fasting and time-restricted eating.

Topics include:

Explore the EASD 2025 Annual Meeting session and view our speakers’ profiles:

For more content from our previous episodes, visit our podcast archive.

Watch the full episode on YouTube or listen on your preferred podcast platform to explore the SURPASS-CVOT trial results. In this episode, EASD TV Host, Vivienne Parry sits with Prof. Tina Vilsbøll (EASD Honorary Secretary) and Prof. Hertzel Gerstein (EASD Independent Advisor and McMaster University) as they explain how tirzepatide performs compared to dulaglutide in cardioprotective outcomes. The experts unpack the trial’s implications for clinical practice, highlighting how outcomes trials like this inform personalised medicine, integrate care between diabetologists and cardiologists, and generate new hypotheses in areas such as liver disease, cognitive function, and obesity management

Learn more about the trial and its relevance for clinical practice, multi-specialist care, and future research directions, including the integration of cardiovascular, liver, and cognitive outcomes into comprehensive diabetes management.

Explore the latest EASD 2025 Annual Meeting presentations and view our speakers’ profiles:

For more content from our previous episodes, visit our podcast archive.

Watch the full video on YouTube to hear Prof. Hindrik Mulder, editor-in-chief of Diabetologia, reflect on the scientific clinical and societal forces shaping the future of diabetes research.

In this episode, we explore:

Start the year with insights from the editor's desk and discover what's next in diabetes research.

Explore Prof. Mulder's profile and the Diabetologia Symposium from the EASD Annual Meeting 2025:

For more conversations with leading voices in diabetes research, visit our podcast archive

Watch the full video on YouTube to learn more about the SURPASS-PEDS trial and the first use of a dual GIP/GLP-1 agonist in adolescents with type 2 diabetes. Explore background research on youth-onset type 2 diabetes, including rising incidence, weight-gain velocity, and metabolic progression.

Explore the latest EASD 2025 Annual Meeting presentations and view our speakers’ profiles:

For more content from our previous episodes, visit our podcast archive.

Watch the full conversation on YouTube to learn about the very first EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes and type 2 diabetes and how it marks a major shift toward recognising the emotional and psychological burden of living with diabetes.

In this episode, Vivienne Parry speaks with:

🎧 Hear how the panel explains the definition of diabetes distress, the evidence gaps, the role of assessment tools, psychological interventions, and how healthcare systems can better support people living with diabetes. Listen now for a behind-the-scenes look at how this landmark guideline came together and how it aims to transform the future of diabetes care.

Visit our speakers’ profiles to learn about their work:

Watch the full video from the EASD 2025 Annual Meeting to learn more about the emerging global consensus on screening for early-stage type 1 diabetes and its implications for clinical practice, public health, and prevention research.

In this episode, Annette Ziegler (Helmholtz Munich), Chantal Mathieu (KU Leuven & EASD President), and Anastasia Albanese-O’Neill (Breakthrough T1D) discuss:

Stay tuned for more expert insights and breakthrough conversations from EASD TV. To learn more about our expert speakers:

Watch the full video on YouTube to explore the cardiologist’s perspective on one of the most important cardiovascular outcomes trials in recent years.

In this episode, Vivienne Parry speaks with Dr Matthew Cavender (University of North Carolina) about the SOUL trial, which evaluated the cardiovascular impact of oral semaglutide in more than 8,000 people with type 2 diabetes.

They discuss:

🎧 Listen now for a clear, accessible breakdown of a landmark study reshaping diabetes and cardiovascular risk management. To learn more about our expert speaker:

Watch the full interview on YouTube to learn more about the SOUL trial, a landmark study presented at the EASD 2025 Annual Meeting investigating cardiovascular outcomes with an oral GLP-1 receptor agonist.

In this episode, Dr Rodica Busui (Oregon Health & Science University-OHSU, Oregon, USA) explains why the SOUL trial represents a significant milestone in diabetes and cardiovascular care. She discusses how the oral formulation achieved a 14% reduction in major adverse cardiovascular events (MACE), matching results previously observed with injectable GLP-1 therapies.

Dr Busui also explores:

Read the full publication for a deeper dive into the SOUL trial data once available online.

Stay tuned for more expert insights and breakthrough conversations from EASD TV. To learn more about our expert speaker: